← Evidence map

ArticleJAMA oncology2024

Quantification of Treatment Effect of Tislelizumab vs Sorafenib for Hepatocellular Carcinoma.

Ryan Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38483380